- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04947358
Longitudinal Observational Study for mIddle Term Follow-up Patients Admitted for Acute Dyspnea in TunIsia (SIDI)
June 23, 2021 updated by: S Form Pharma
The purpose of the SIDI study is to follow, few months after discharge from the hospital, the patients admitted to the 3 emergency departments in Tunisia for acute dyspnea and to determine the proportion and the factors favoring rehospitalization and death.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Anticipated)
180
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eric Halioua, CEO
- Phone Number: +32474057866
- Email: halioua_eric@yahoo.fr
Study Locations
-
-
-
Monastir, Tunisia
- Recruiting
- ER, Fattouma Bourguiba Hospital
-
Contact:
- Semir Nouira
- Phone Number: +21673106085
- Email: semir.nouira@rns.tn
-
Principal Investigator:
- Riadh Boukef
-
Principal Investigator:
- Houda Ben Soltane
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients admitted for unexpected respiratory difficulty
Description
Inclusion Criteria:
- Patients admitted for unexpected respiratory difficulty
- Patient admitted to the emergency department
- One of the following 3 criteria have to be present at admission to the ER:
- O2 < or = 95%
- Respiratory rate RR > or = 20
- Suffocation sensation
Exclusion Criteria:
- Patients <18 years old and> 85 years' old
- Pregnancy
- History of allergic asthma at early age
- Diagnosis retained of pulmonary embolism
- Patients with heart failure (HF) with left ventricular ejection fraction LVEF <40% are known beforehand or discovered at admission to ER
- known Allergy for Polyamide; Polyester; Elastane; Silicone; Silver; Synthetic material Cardiorespiratory disorders which may be aggravated by the slight compression of the thorax Open wound on the skin, at the level of the trunk
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion and causes of re-hospitalization and deaths within 3 months of discharge from hospital
Time Frame: 3 months
|
Define the proportion and causes of re-hospitalization and deaths within 3 months of discharge from hospital for patients admitted to the Emergency Department for acute dyspnea
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion and causes of re-hospitalization and deaths within 6 months of discharge from hospital
Time Frame: 6 months
|
Check theses parameters at 6 months, differentiating the cardiac causes from non-cardiac causes and the effect of home follow-up.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 22, 2019
Primary Completion (Anticipated)
December 30, 2021
Study Completion (Anticipated)
December 30, 2021
Study Registration Dates
First Submitted
July 19, 2019
First Submitted That Met QC Criteria
June 23, 2021
First Posted (Actual)
July 1, 2021
Study Record Updates
Last Update Posted (Actual)
July 1, 2021
Last Update Submitted That Met QC Criteria
June 23, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AD201801
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Longitudinal Observational Study With 6 Months Follow-up
-
Alaa Gameil Abd El-salam HussienAssiut UniversityActive, not recruitingThe Aim of This Study is to Follow up Short Term "3-6 Months"& Mid Term" 6-12months "Outcomes of Vascular Access" Native and Synthetic "in ESRD PediatricsEgypt
-
Group of Research in Minimally Invasive TechniquesUnknownObservational Study | Pelvic Congestion Syndrome | Embolization, Therapeutic | Pelvic Varicose Veins | Follow-up StudySpain
-
University of Sao Paulo General HospitalUnknownthe Focus of This Study is to Develop an Application for Postoperative Follow-up of Patients With Prostate Cancer